Published in Lancet Infect Dis on November 01, 2005
Rheumatic Heart Disease Study in Lusaka | NCT02661763
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol (2011) 3.48
Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci U S A (2006) 3.33
Participatory medicine: A home score for streptococcal pharyngitis enabled by real-time biosurveillance: a cohort study. Ann Intern Med (2013) 3.32
Targeted quantitative analysis of Streptococcus pyogenes virulence factors by multiple reaction monitoring. Mol Cell Proteomics (2008) 3.29
Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol (2011) 2.81
Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol (2009) 2.80
World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline. Nat Rev Cardiol (2012) 2.75
Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A (2014) 2.63
Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc Natl Acad Sci U S A (2010) 2.43
Antibody orientation at bacterial surfaces is related to invasive infection. J Exp Med (2012) 2.30
Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J (2014) 2.22
Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev (2014) 2.20
Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol (2010) 2.13
No demonstrable effect of benzathine penicillin on recurrence of rheumatic Fever in pacific island population. Pediatr Cardiol (2010) 2.12
Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. Arch Intern Med (2012) 2.09
Are mean platelet volume and platelet distribution width useful parameters in children with acute rheumatic carditis? Pediatr Cardiol (2013) 2.08
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine (2011) 1.98
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev (2015) 1.94
The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol (2011) 1.88
Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol (2010) 1.75
Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol (2011) 1.73
The globally disseminated M1T1 clone of group A Streptococcus evades autophagy for intracellular replication. Cell Host Microbe (2013) 1.70
Rheumatic Fever and Rheumatic Heart Disease a Historical Perspective. Heart Views (2016) 1.69
The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. Cell Host Microbe (2008) 1.68
Genome sequence of a nephritogenic and highly transformable M49 strain of Streptococcus pyogenes. J Bacteriol (2008) 1.67
Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance. FEMS Microbiol Rev (2011) 1.66
The utility of handheld echocardiography for early rheumatic heart disease diagnosis: a field study. Eur Heart J Cardiovasc Imaging (2015) 1.61
An extracellular bacterial pathogen modulates host metabolism to regulate its own sensing and proliferation. Cell (2014) 1.61
Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol (2013) 1.59
Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone. J Infect Dis (2010) 1.57
Emergence of a New Highly Successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United Kingdom. MBio (2015) 1.54
Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa. Heart (2007) 1.50
Streptolysin O promotes group A Streptococcus immune evasion by accelerated macrophage apoptosis. J Biol Chem (2008) 1.49
Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol (2007) 1.48
Group A Streptococcal M1 Protein Sequesters Cathelicidin to Evade Innate Immune Killing. Cell Host Microbe (2015) 1.46
Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010. Clin Infect Dis (2012) 1.44
Rheumatic fever & rheumatic heart disease: the last 50 years. Indian J Med Res (2013) 1.44
A 39-year-old man with recurrent rheumatic fever. CMAJ (2014) 1.44
Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol (2009) 1.43
Maltodextrin utilization plays a key role in the ability of group A Streptococcus to colonize the oropharynx. Infect Immun (2006) 1.42
Prediction of residual valvular lesions in rheumatic heart disease: role of adhesion molecules. Pediatr Cardiol (2012) 1.39
Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania. Nat Commun (2017) 1.38
Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. J Biol Chem (2008) 1.38
A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis (2009) 1.35
High burden of impetigo and scabies in a tropical country. PLoS Negl Trop Dis (2009) 1.35
Review of mitral valve insufficiency: repair or replacement. J Thorac Dis (2014) 1.32
Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010. Emerg Infect Dis (2011) 1.32
Potential coverage of a multivalent M protein-based group A streptococcal vaccine. Vaccine (2013) 1.32
Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2013) 1.31
Prevalence and pattern of rheumatic heart disease in the Nigerian savannah: an echocardiographic study. Cardiovasc J Afr (2007) 1.30
A decade of molecular pathogenomic analysis of group A Streptococcus. J Clin Invest (2009) 1.30
Screening for rheumatic heart disease: current approaches and controversies. Nat Rev Cardiol (2012) 1.29
Synthetic riboswitches that induce gene expression in diverse bacterial species. Appl Environ Microbiol (2010) 1.29
Mode of expression and functional characterization of FCT-3 pilus region-encoded proteins in Streptococcus pyogenes serotype M49. Infect Immun (2008) 1.28
Population biology of the human restricted pathogen, Streptococcus pyogenes. Infect Genet Evol (2009) 1.27
Virulence of serotype M3 Group A Streptococcus strains in wax worms (Galleria mellonella larvae). Virulence (2011) 1.23
Open heart surgery in Nigeria; a work in progress. J Cardiothorac Surg (2013) 1.22
Streptolysin S inhibits neutrophil recruitment during the early stages of Streptococcus pyogenes infection. Infect Immun (2009) 1.20
A naturally occurring mutation in ropB suppresses SpeB expression and reduces M1T1 group A streptococcal systemic virulence. PLoS One (2008) 1.19
The Streptococcus pyogenes serotype M49 Nra-Ralp3 transcriptional regulatory network and its control of virulence factor expression from the novel eno ralp3 epf sagA pathogenicity region. Infect Immun (2007) 1.19
Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study. Clin Microbiol Infect (2013) 1.18
Genome-wide identification of genes required for fitness of group A Streptococcus in human blood. Infect Immun (2013) 1.18
Genes, autoimmunity and pathogenesis of rheumatic heart disease. Ann Pediatr Cardiol (2011) 1.17
M1T1 group A streptococcal pili promote epithelial colonization but diminish systemic virulence through neutrophil extracellular entrapment. J Mol Med (Berl) (2009) 1.17
tRNA modification by GidA/MnmE is necessary for Streptococcus pyogenes virulence: a new strategy to make live attenuated strains. Infect Immun (2008) 1.16
Streptolysin S contributes to group A streptococcal translocation across an epithelial barrier. J Biol Chem (2010) 1.16
Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986-1996-2002). Cardiovasc J Afr (2008) 1.15
Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis (2013) 1.14
Cardiovascular complications in newly diagnosed rheumatic heart disease patients at Mulago Hospital, Uganda. Cardiovasc J Afr (2013) 1.14
The secreted esterase of group a streptococcus is important for invasive skin infection and dissemination in mice. Infect Immun (2009) 1.13
Molecular characterization of the 2011 Hong Kong scarlet fever outbreak. J Infect Dis (2012) 1.13
The plasminogen-binding group A streptococcal M protein-related protein Prp binds plasminogen via arginine and histidine residues. J Bacteriol (2006) 1.13
Global research priorities in rheumatic fever and rheumatic heart disease. Ann Pediatr Cardiol (2011) 1.13
Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob Agents Chemother (2007) 1.12
Defining the structural basis of human plasminogen binding by streptococcal surface enolase. J Biol Chem (2009) 1.12
High burden of invasive beta-haemolytic streptococcal infections in Fiji. Epidemiol Infect (2007) 1.12
Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis. Pediatr Nephrol (2010) 1.11
Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes. J Clin Microbiol (2011) 1.11
Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood (2008) 1.10
emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: What has changed in 11 years? J Clin Microbiol (2007) 1.09
Microevolution of group A streptococci in vivo: capturing regulatory networks engaged in sociomicrobiology, niche adaptation, and hypervirulence. PLoS One (2010) 1.09
Proteome-wide selected reaction monitoring assays for the human pathogen Streptococcus pyogenes. Nat Commun (2012) 1.09
Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance. BMC Microbiol (2012) 1.08
Postpartum invasive group A streptococcal disease in the modern era. Infect Dis Obstet Gynecol (2008) 1.08
Robust antigen specific th17 T cell response to group A Streptococcus is dependent on IL-6 and intranasal route of infection. PLoS Pathog (2011) 1.07
Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in mice. Proc Natl Acad Sci U S A (2012) 1.07
Whole-genome association study on tissue tropism phenotypes in group A Streptococcus. J Bacteriol (2011) 1.06
emm and C-repeat region molecular typing of beta-hemolytic Streptococci in a tropical country: implications for vaccine development. J Clin Microbiol (2009) 1.06
Molecular characterization of group A Streptococcus maltodextrin catabolism and its role in pharyngitis. Mol Microbiol (2008) 1.06
Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature. Am J Trop Med Hyg (2011) 1.05
Characteristics of group A Streptococcus strains circulating during scarlet fever epidemic, Beijing, China, 2011. Emerg Infect Dis (2013) 1.05
Normal ranges of streptococcal antibody titers are similar whether streptococci are endemic to the setting or not. Clin Vaccine Immunol (2008) 1.04
Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine. Infect Immun (2010) 1.04
Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates. Eur J Clin Microbiol Infect Dis (2011) 1.04
Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings. J Hypertens (2014) 1.04
First Streptococcus pyogenes signature-tagged mutagenesis screen identifies novel virulence determinants. Infect Immun (2009) 1.04
Tissue tropisms in group A streptococcal infections. Future Microbiol (2010) 1.03
Variation in Streptococcus pyogenes NAD+ glycohydrolase is associated with tissue tropism. J Bacteriol (2010) 1.03
Gaps in policy-relevant information on burden of disease in children: a systematic review. Lancet (2005) 4.64
Mass Drug Administration for Scabies Control in a Population with Endemic Disease. N Engl J Med (2015) 4.06
Indoor air pollution from unprocessed solid fuel use and pneumonia risk in children aged under five years: a systematic review and meta-analysis. Bull World Health Organ (2008) 3.82
Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ (2005) 3.36
Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat Clin Pract Cardiovasc Med (2008) 2.72
Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) (2008) 2.64
Risk of low birth weight and stillbirth associated with indoor air pollution from solid fuel use in developing countries. Epidemiol Rev (2010) 2.63
Predictors of neonatal sepsis in developing countries. Pediatr Infect Dis J (2003) 2.10
Pneumonia research to reduce childhood mortality in the developing world. J Clin Invest (2008) 2.01
An epidemiological study of RSV infection in the Gambia. Bull World Health Organ (2002) 1.97
Pneumonia case-finding in the RESPIRE Guatemala indoor air pollution trial: standardizing methods for resource-poor settings. Bull World Health Organ (2007) 1.90
Global initiatives for improving hospital care for children: state of the art and future prospects. Pediatrics (2008) 1.73
The prevalence of hypoxaemia among ill children in developing countries: a systematic review. Lancet Infect Dis (2009) 1.73
Methodological and quality issues in epidemiological studies of acute lower respiratory infections in children in developing countries. Int J Epidemiol (2004) 1.72
High prevalence of rheumatic heart disease by clinical and echocardiographic screening among children in Fiji. J Heart Valve Dis (2009) 1.72
Comparative impact assessment of child pneumonia interventions. Bull World Health Organ (2009) 1.49
Group A streptococcus meningitis in children. Pediatr Infect Dis J (2013) 1.44
Development of paediatric quality of inpatient care indicators for low-income countries - A Delphi study. BMC Pediatr (2010) 1.44
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine (2008) 1.43
Bronchiectasis in indigenous children in remote Australian communities. Med J Aust (2002) 1.38
High burden of impetigo and scabies in a tropical country. PLoS Negl Trop Dis (2009) 1.35
siRNA stabilization prolongs gene knockdown in primary T lymphocytes. Eur J Immunol (2008) 1.30
Pilot study of nurse-led rheumatic heart disease echocardiography screening in Fiji--a novel approach in a resource-poor setting. Cardiol Young (2012) 1.17
Systematic Review: Estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis. Trop Med Int Health (2011) 1.16
The active site of cellobiohydrolase Cel6A from Trichoderma reesei: the roles of aspartic acids D221 and D175. J Am Chem Soc (2002) 1.15
Scabies: a suitable case for a global control initiative. Curr Opin Infect Dis (2013) 1.13
Distinguishing malaria from severe pneumonia among hospitalized children who fulfilled integrated management of childhood illness criteria for both diseases: a hospital-based study in Mozambique. Am J Trop Med Hyg (2011) 1.12
Group A streptococcal vaccines: paving a path for accelerated development. Vaccine (2013) 1.12
Streptococcal skin infection and rheumatic heart disease. Curr Opin Infect Dis (2012) 1.12
The C terminus (amino acids 75-94) and the linker region (amino acids 42-54) of the Ca2+-binding protein S100A1 differentially enhance sarcoplasmic Ca2+ release in murine skinned skeletal muscle fibers. J Biol Chem (2003) 1.11
Bacterial infections--a major cause of death among children in Africa. N Engl J Med (2005) 1.09
Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis (2009) 1.07
Life-threatening bleeding after dental extraction in a hemophilia A patient with inhibitors to factor VIII: a case report. J Oral Maxillofac Surg (2003) 1.00
Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination. Vaccine (2013) 1.00
RNA interference: PCR strategies for the quantification of stable degradation-fragments derived from siRNA-targeted mRNAs. Biomol Eng (2004) 1.00
Treating auditory hallucinations by transcranial magnetic stimulation: a randomized controlled cross-over trial. Neuropsychobiology (2006) 0.99
Increased risk of hospitalization for acute lower respiratory tract infection among Australian indigenous infants 5-23 months of age following pneumococcal vaccination: a cohort study. Clin Infect Dis (2010) 0.98
Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders. Curr Top Behav Neurosci (2012) 0.97
Effect of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian children. J Clin Microbiol (2011) 0.96
The high burden of rheumatic heart disease found on autopsy in Fiji. Cardiol Young (2007) 0.96
Hospital care for children in developing countries: clinical guidelines and the need for evidence. J Trop Pediatr (2006) 0.96
Multilocus sequence typing of Streptococcus pneumoniae by use of mass spectrometry. J Clin Microbiol (2011) 0.96
Dying with dementia: symptom burden, quality of care, and place of death. Dtsch Arztebl Int (2013) 0.96
Accessing and understanding the evidence. Bull World Health Organ (2006) 0.95
Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Fiji. Sex Health (2011) 0.95
Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005-2007. Med J Aust (2009) 0.94
Factors influencing place of death in Germany. J Pain Symptom Manage (2011) 0.94
Reliability of radiologic assessment of the fracture anatomy at the posterior tibial plafond in malleolar fractures. J Orthop Trauma (2009) 0.94
Dendritic polyamines: simple access to new materials with defined treelike structures for application in nonviral gene delivery. Chembiochem (2004) 0.93
GluN2B antagonism affects interneurons and leads to immediate and persistent changes in synaptic plasticity, oscillations, and behavior. Neuropsychopharmacology (2013) 0.93
Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. J Bone Joint Surg Am (2008) 0.92
Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease. Br J Haematol (2011) 0.92
Molecular epidemiology of Streptococcus pneumoniae serogroup 6 isolates from Fijian children, including newly identified serotypes 6C and 6D. J Clin Microbiol (2010) 0.92
End-of-life care in Germany: Study design, methods and first results of the EPACS study (Establishment of Hospice and Palliative Care Services in Germany). BMC Palliat Care (2010) 0.91
Muscarinic and nicotinic ACh receptor activation differentially mobilize Ca2+ in rat intracardiac ganglion neurons. J Neurophysiol (2003) 0.89
Detection of group a streptococcal pharyngitis by quantitative PCR. BMC Infect Dis (2013) 0.89
Preference for place of death in Germany. J Palliat Med (2011) 0.87
Acute rheumatic fever: an important differential diagnosis of septic arthritis. J Trop Pediatr (2008) 0.85
Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortium. J Clin Oncol (2009) 0.84
Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG. BMC Res Notes (2013) 0.84
Group A streptococcus colonies from a single throat swab can have heterogeneous antimicrobial susceptibility patterns. Pediatr Infect Dis J (2013) 0.84
Mapping the conformational space accessible to BACE2 using surface mutants and cocrystals with Fab fragments, Fynomers and Xaperones. Acta Crystallogr D Biol Crystallogr (2013) 0.84
Calcific tendinitis of the peroneus longus: case report. Foot Ankle Int (2011) 0.84
[The transfibular approach for ankle arthrodesis]. Oper Orthop Traumatol (2005) 0.83
Targeting gene delivery to activated vascular endothelium using anti E/P-Selectin antibody linked to PAMAM dendrimers. J Immunol Methods (2009) 0.83
Symptom prevalence in the last days of life in Germany: the role of place of death. Am J Hosp Palliat Care (2011) 0.83
Inhibition of AP-1 signaling by JDP2 overexpression protects cardiomyocytes against hypertrophy and apoptosis induction. Cardiovasc Res (2013) 0.83
Clinical predictors of bacterial meningitis in infants and young children in The Gambia. Trop Med Int Health (2002) 0.83
Biochemical T2* MR quantification of ankle arthrosis in pes cavovarus. J Orthop Res (2010) 0.82
The "flap-shaft" prosthesis for insensate feet with Chopart or Lisfranc amputations. Foot Ankle Int (2007) 0.82
Ankle dorsiflexion arthrodesis to salvage Chopart's amputation with anterior skin insufficiency. Foot Ankle Int (2013) 0.82
Rheumatic heart disease and its control in the Pacific. Expert Rev Cardiovasc Ther (2009) 0.82
Generation, characterization and structural data of chymase binding proteins based on the human Fyn kinase SH3 domain. MAbs (2012) 0.81
The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J mice. Behav Pharmacol (2010) 0.81
Setting standards for essential children's medicines. Bull World Health Organ (2007) 0.81
Supramalleolar lateral closing wedge osteotomy for the treatment of varus ankle arthrosis. Foot Ankle Int (2007) 0.81
Ivermectin worthy of further investigation. Bull World Health Organ (2009) 0.81
Dendritic polyglycerols with oligoamine shells show low toxicity and high siRNA transfection efficiency in vitro. Bioconjug Chem (2010) 0.81
Community-associated methicillin-resistant Staphylococcus aureus skin infections in the tropics. Dermatol Clin (2011) 0.80
Assessing somatic, psychosocial, and spiritual distress of patients with advanced cancer: development of the Advanced Cancer Patients' Distress Scale. Am J Hosp Palliat Care (2012) 0.80
Antibodies present in normal human serum inhibit invasion of human brain microvascular endothelial cells by Listeria monocytogenes. Infect Immun (2003) 0.80
Molecular Epidemiology of Group A Streptococcus Infections in Cambodian Children, 2007-2012. Pediatr Infect Dis J (2015) 0.80
Communicating asset risk: how name recognition and the format of historic volatility information affect risk perception and investment decisions. Risk Anal (2005) 0.80
Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies. Pharmacol Biochem Behav (2008) 0.80
Hindfoot joint pressure in supination sprains. Am J Sports Med (2012) 0.79
Parametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats. Pharmacol Biochem Behav (2010) 0.79
Medical mystery: painless ulcers--the answer. N Engl J Med (2004) 0.79
Environmental factors and rheumatic heart disease in Fiji. Pediatr Cardiol (2011) 0.78
Opportunities to investigate the effects of ivermectin mass drug administration on scabies. Parasit Vectors (2013) 0.78
Investigation and control of an outbreak of Enterobacter aerogenes bloodstream infection in a neonatal intensive care unit in Fiji. Infect Control Hosp Epidemiol (2009) 0.78
Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in rats. Brain Res (2011) 0.78
The high burden of cervical cancer in Fiji, 2004-07. Sex Health (2013) 0.78
Arthroscopically assisted removal of intraosseous ganglion cysts of the distal tibia. Clin Orthop Relat Res (2009) 0.77
The treatment of imported malaria in children: an update. Arch Dis Child Educ Pract Ed (2012) 0.77
A novel visuospatial priming task for rats with relevance to Tourette syndrome and modulation of dopamine levels. Neurosci Biobehav Rev (2012) 0.77
Preservation of lesser metatarsophalangeal joints in rheumatoid forefoot reconstruction. Foot Ankle Int (2011) 0.77
Secondary prophylaxis is important for the prevention of recurrent rheumatic fever in the Pacific. Pediatr Cardiol (2011) 0.77
Comparison of citrated human blood, citrated sheep blood, and defibrinated sheep blood Mueller-Hinton agar preparations for antimicrobial susceptibility testing of Streptococcus pneumoniae isolates. J Clin Microbiol (2010) 0.76
Adoptive immunotherapy in chimeras with donor lymphocytes. Acta Haematol (2003) 0.75